Bio-IT World Asia 2013 Conference will bring together, life sciences, pharmaceutical, informatics and IT professionals from all over Asia and the rest of the world to one unique location.

Sixth Annual Targeting Pain with Novel Therapeutics conference brings together leading pain researchers from pharma and academia to present the latest findings from across the field and offers a forum to hear both new clinical data and unpublished pre-cli

The kinase inhibitor field is maturing.

Novel constructs, such as anti-drug conjugates (ADCs) and bispecific antibodies, now exist as promising candidates in biotherapeutic pipelines. With aggressive timelines and contraction in the biopharma labor force, assay development can pose challenges beyond typical assays for pharmacokinetics and pharmacodynamics. Several bioanalytical techniques can be employed to measure these novel constructs. This short course will cover assay technologies to measure ADCs and bi-specific antibody therapeutics for pharmacokinetics and pharmacodynamics presented by various biopharma scientists.

Epethelial Mesenchymal Transition (EMT) plays a critical role in cancer cells, but understanding of its mechanisms is incomplete. EMT causes cells to develop increased motility, invasiveness, and greater resistance to apoptosis. These changes make the cells more like stem cells, allowing them to self renew. This course provides a framework of the underlying molecular mechanisms while addressing stem cells, and cancer progression, cMET and their activity as anti-metastasis agents, and the Mesenchymal-Epethelial Transition (MET) as an essential process for tumor re-initiation, colonization, and metastasis.

This course will focus on validation of CTC research data for clinical practice, correlations between CTCs, diagnosis and responses to therapy.